VEGFA and age-related macular degeneration: Thus, a recent study by Enders et al. demonstrated that in patients with AMD plasma levels of VEGF were decreased at 12 months post initiation of RBZ therapy by ∼39% [35] and it is likely that the same effect may be present in patients with DME.